Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
10 "Thyroid neoplasms"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Endocrine cancer
Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAFV600E-Mutated Thyroid Cancer
Youngkyung Jeon, Sehhoon Park, Se-Hoon Lee, Tae Hyuk Kim, Sun Wook Kim, Myung-Ju Ahn, Hyun Ae Jung, Jae Hoon Chung
Cancer Res Treat. 2024;56(4):1270-1276.   Published online March 6, 2024
DOI: https://doi.org/10.4143/crt.2023.1278
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
BRAF mutations are detected in 30%-80% of papillary thyroid cancer (PTC) cases. DaBRAFenib and trametinib showed promising antitumor activity in patients with BRAFV600E-mutated metastatic melanoma and non–small cell lung cancer. This study aimed to evaluate the efficacy and safety of daBRAFenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer.
Materials and Methods
This was a retrospective study to evaluate the efficacy of daBRAFenib and trametinib in patients with metastatic BRAFV600E-mutated PTC. The patients received daBRAFenib 150 mg twice daily and trametinib 2 mg once daily at the Samsung Medical Center. This study evaluated the progression-free survival (PFS), objective response rate (ORR), disease control rate (DCR) overall survival (OS), and safety of daBRAFenib and trametinib.
Results
Between December 2019 and January 2022, 27 PTC patients including eight patients with poorly differentiated or anaplastic transformation, received daBRAFenib and trametinib. The median age was 73.0 years, and the median follow-up period was 19.8 months. The majority (81.5%) had undergone thyroidectomy, while 8 patients had received prior systemic treatments. ORR was 73.1%, with 19 partial responses, and DCR was 92.3%. Median PFS was 21.7 months, and median OS was 21.7 months. Treatment-related adverse events included generalized weakness (29.6%), fever (25.9%), and gastrointestinal problems (22.2%). Dose reduction due to adverse events was required in 81.5% of the patients.
Conclusion
DaBRAFenib and trametinib demonstrated a high ORR with promising PFS; however, most patients with BRAFV600E-mutated metastatic PTC required a dose reduction.

Citations

Citations to this article as recorded by  
  • Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 4. Systemic Therapy for Progressive Radioiodine-Refractory Differentiated Thyroid Cancer 2
    Dong Yeob Shin, Ho-Cheol Kang, Sun Wook Kim, Dong Gyu Na, Young Joo Park, Young Shin Song, Eun Kyung Lee, Dong-Jun Lim, Yun Jae Chung, Won Gu Kim
    International Journal of Thyroidology.2024; 17(1): 168.     CrossRef
  • Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN–ALK Fusion In Vitro
    Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, Valeria Mazzi, Eugenia Balestri, Chiara Botrini, Licia Rugani, Armando Patrizio, Simona Piaggi, Concettina La Motta, Salvatore Ulisse, Camilla Virili, Alessandro Antonelli, Poupak Fallahi
    International Journal of Molecular Sciences.2024; 25(12): 6734.     CrossRef
  • The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review
    Odysseas Violetis, Panagiota Konstantakou, Ariadni Spyroglou, Antonios Xydakis, Panagiotis B. Kekis, Sofia Tseleni, Denise Kolomodi, Manousos Konstadoulakis, George Mastorakos, Maria Theochari, Javier Aller, Krystallenia I. Alexandraki
    Journal of Personalized Medicine.2024; 14(6): 654.     CrossRef
  • Treatment of Unresectable BRAF V600E, TERT-Mutated Differentiated Papillary Thyroid Cancer With Dabrafenib and Trametinib
    Neha Bapat, Tatiana Ferraro, Layal Esper, Arjun S Joshi, Faysal Haroun, Chelsey K Baldwin
    JCEM Case Reports.2024;[Epub]     CrossRef
  • Trametinib

    Reactions Weekly.2024; 2035(1): 467.     CrossRef
  • 2,590 View
  • 378 Download
  • 2 Web of Science
  • 5 Crossref
Close layer
Endocrine Cancer
Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea
Tung Hoang, Dayoung Song, Jeonghee Lee, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
Cancer Res Treat. 2021;53(3):857-873.   Published online December 7, 2020
DOI: https://doi.org/10.4143/crt.2020.720
AbstractAbstract PDFPubReaderePub
Purpose
Obesity has been determined to be associated with fat mass and obesity-associated (FTO) gene and thyroid cancer risk. However, the effect of combined interactions between obesity and the FTO gene on thyroid cancer needs further investigation. This study aimed to examine whether interactions between body mass index (BMI) and the FTO gene are associated with an increased risk of thyroid cancer.
Materials and Methods
A total of 705 thyroid cancer cases and 705 sex- and age-matched normal controls were selected from the Cancer Screenee Cohort in National Cancer Center, Korea. A conditional logistic regression model was used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) for the measure of associations and the combined effect of BMI and FTO gene on thyroid cancer.
Results
BMI was associated with an increased risk of thyroid cancer in subclasses of overweight (23-24.9 kg/m2; adjusted OR, 1.50; 95% CI, 1.12 to 2.00) and obese (≥ 25 kg/m2) (adjusted OR, 1.62; 95% CI, 1.23 to 2.14). There were positive associations between the FTO genetic variants rs8047395 and rs8044769 and an increased risk of thyroid cancer. Additionally, the combination of BMI subclasses and FTO gene variants was significantly associated with thyroid cancer risk in the codominant (rs17817288), dominant (rs9937053, rs12149832, rs1861867, and rs7195539), and recessive (rs17817288 and rs8044769) models.
Conclusion
Findings from this study identified the effects of BMI on thyroid cancer risk among individuals carrying rs17817288, rs9937053, rs12149832, rs1861867, rs7195539, and rs8044769, whereas the effects of BMI may be modified according to individual characteristics of other FTO variants.

Citations

Citations to this article as recorded by  
  • Exploring the Link between BMI and Aggressive Histopathological Subtypes in Differentiated Thyroid Carcinoma—Insights from a Multicentre Retrospective Study
    Giacomo Di Filippo, Gian Luigi Canu, Giovanni Lazzari, Dorin Serbusca, Eleonora Morelli, Paolo Brazzarola, Leonardo Rossi, Benard Gjeloshi, Mariangela Caradonna, George Kotsovolis, Ioannis Pliakos, Efthymios Poulios, Theodosios Papavramidis, Federico Capp
    Cancers.2024; 16(7): 1429.     CrossRef
  • Analysis of Body Mass Index and Clinicopathological Factors in Patients with Papillary Thyroid Carcinoma
    Wei Yan, Xue Luo, Qing-Jun Gao, Bing-Feng Chen, Hui Ye
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 2013.     CrossRef
  • Human adipose-derived stem cells promote migration of papillary thyroid cancer cell via leptin pathway
    Bo-Tao Zhang, Ying Li, Qi-Lan Jiang, Rui Jiang, Yang Zeng, Jun Jiang
    Annals of Medicine.2024;[Epub]     CrossRef
  • The association of obesity with thyroid carcinoma risk
    Xiao‐Ni Ma, Cheng‐Xu Ma, Li‐Jie Hou, Song‐Bo Fu
    Cancer Medicine.2022; 11(4): 1136.     CrossRef
  • Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer
    Tung Hoang, Eun Kyung Lee, Jeonghee Lee, Yul Hwangbo, Jeongseon Kim
    Endocrinology and Metabolism.2022; 37(3): 513.     CrossRef
  • Low-Level Environmental Mercury Exposure and Thyroid Cancer Risk Among Residents Living Near National Industrial Complexes in South Korea: A Population-Based Cohort Study
    Seyoung Kim, Sang-Hwan Song, Chul-Woo Lee, Jung-Taek Kwon, Eun Young Park, Jin-Kyoung Oh, Hyun-Jin Kim, Eunjung Park, Byungmi Kim
    Thyroid.2022; 32(9): 1118.     CrossRef
  • Association between Obesity Indexes and Thyroid Cancer Risk in Korean Women: Nested Case–Control Study
    Yoonyoung Jang, Taehwa Kim, Brian H. S. Kim, Boyoung Park
    Cancers.2022; 14(19): 4712.     CrossRef
  • FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma
    Feng Xiao, Jianrong Zhou
    Pharmacogenomics and Personalized Medicine.2021; Volume 14: 1239.     CrossRef
  • 6,703 View
  • 175 Download
  • 8 Web of Science
  • 8 Crossref
Close layer
Changes in the Diagnostic Efficiency of Thyroid Fine-Needle Aspiration Biopsy during the Era of Increased Thyroid Cancer Screening in Korea
Young Ki Lee, Kyeong Hye Park, Young Duk Song, Taemi Youk, Joo Young Nam, Sun Ok Song, Dong Yeob Shin, Eun Jig Lee
Cancer Res Treat. 2019;51(4):1430-1436.   Published online February 26, 2019
DOI: https://doi.org/10.4143/crt.2018.534
AbstractAbstract PDFPubReaderePub
Purpose
The volume of thyroid cancer screening and subsequent thyroid fine-needle aspiration (FNA) have rapidly increased in South Korea. We analyzed the thyroid cancer diagnoses/thyroid FNA ratio according to the annual number of FNA to evaluate changes in the diagnostic efficiency of FNA.
Materials and Methods
This was a nationwide population-based retrospective cohort study. The overall thyroid cancer diagnoses/thyroid FNA ratio and annual incremental thyroid cancer diagnoses/incremental thyroid FNA ratio were indirectly calculated using data obtained from the Korea Central Cancer Registry database and the Korean National Health Insurance Service claims database from 2004 to 2012. Pearson correlation analyses were performed to evaluate the strength of linear associations between variables.
Results
The number of thyroid FNA increased from 28,596 to 177,805 (6.2-fold increase) from 2004 to 2012. The overall thyroid cancer diagnoses/thyroid FNA ratio decreased from 36.5% in 2004 to 25.1% in 2012 and was negatively correlated to the number of FNA (R=‒0.977, p < 0.001). The annual incremental thyroid cancer diagnoses/incremental thyroid FNA ratios (range, 15.3% to 30.7%) were always lower than the overall thyroid cancer diagnoses/thyroid FNA ratio in each year and also worsened according to the increase in the number of FNA (R=‒0.853, p=0.007).
Conclusion
The diagnostic performance of both overall and annual incremental thyroid FNA worsened, whereas the number of thyroid FNA procedures increased. More sophisticated indications for FNA are required to improve its diagnostic efficiency, considering the increased burden of screening-detected thyroid nodules.

Citations

Citations to this article as recorded by  
  • Hormonal and other methods of thyroid gland examination: A literature review
    Larysa Soyka, Oksana Kovalchuk, Iryna Upatova
    Bulletin Of Medical And Biological Research.2024; 6(2): 85.     CrossRef
  • Machine-learning-based diagnosis of thyroid fine-needle aspiration biopsy synergistically by Papanicolaou staining and refractive index distribution
    Young Ki Lee, Dongmin Ryu, Seungwoo Kim, Juyeon Park, Seog Yun Park, Donghun Ryu, Hayoung Lee, Sungbin Lim, Hyun-Seok Min, YongKeun Park, Eun Kyung Lee
    Scientific Reports.2023;[Epub]     CrossRef
  • Thyroid surgery during the COVID-19 pandemic: difficulties – how to improve
    Christos K. Stefanou, Georgios Papathanakos, Stefanos K. Stefanou, Kostas Tepelenis, Aikaterini Kitsouli, Alexandra Barbouti, Stefanos Flindris, Periklis Tsoumanis, Panagiotis Kanavaros, Panagiotis Kitsoulis
    Innovative Surgical Sciences.2022; 7(3-4): 125.     CrossRef
  • Comparison of thyroid fine needle aspiration cytology results before and during the COVID-19 pandemic: the impact of the pandemic
    Süleyman ALTINTAŞ, Mehmet BAYRAK
    Cukurova Medical Journal.2022; 47(4): 1471.     CrossRef
  • Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic
    Raffaele Palladino, Ilaria Migliatico, Roberta Sgariglia, Mariantonia Nacchio, Antonino Iaccarino, Umberto Malapelle, Elena Vigliar, Domenico Salvatore, Giancarlo Troncone, Claudio Bellevicine
    Endocrine.2021; 71(1): 20.     CrossRef
  • Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
    Chang‐Mo Oh, Jiwon Lim, Yuh Seog Jung, Yeol Kim, Kyu‐Won Jung, Seri Hong, Young‐Joo Won
    Cancer Medicine.2021; 10(12): 4087.     CrossRef
  • Endemik bölgede tiroid nodüllerinin sonografik özellikleri ve ince iğne aspirasyon biyopsi sonuçlarının değerlendirilmesi
    Özlem DEMİRCİOĞLU
    Journal of Health Sciences and Medicine.2020; 3(3): 336.     CrossRef
  • 7,998 View
  • 174 Download
  • 4 Web of Science
  • 7 Crossref
Close layer
Development and Evaluation of a Korean Version of a Thyroid-Specific Quality-of-Life Questionnaire Scale in Thyroid Cancer Patients
Chang Hwan Ryu, Boram Park, Junsun Ryu, Youn Mi Ryu, Seong Ae Jo, You Jin Lee, Eun-Kyung Lee, Yul Hwangbo, Jungnam Joo, Yuh-Seog Jung
Cancer Res Treat. 2018;50(2):405-415.   Published online May 26, 2017
DOI: https://doi.org/10.4143/crt.2017.012
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to develop a Korean version of the self-reported thyroid-specific quality of life (QoL) questionnaire for thyroid cancer patients (KT-QoL), and to evaluate its reliability and validity.
Materials and Methods
Two hundred seventy-two patients who underwent thyroidectomy from January to December 2010 were recruited in this study. The original version of the thyroid QoL was translated into Korean and evaluated for its reliability and validity. Using the developed KT-QoL, the postoperative QoL was evaluated until postoperative 1 year.
Results
At the preoperative baseline, the item internal consistency (IIC) ranged from ‒0.19 to 0.76, with low IIC values for items 2, 17, and 27. Item discriminant validity ranged from 86% to 97%. These values were similar at the postoperative periods. The internal consistency reliability (Cronbach’s α) was high for all dimensions, ranging from 0.90 to 0.95. The test-retest reliability (intraclass correlation coefficient) was acceptable (0.74-0.82). The external validity examined by the correlation between the item 1j (voice changes) of KT-QoL and the voice handicap index-30 ranged from 0.51 to 0.75. Patients’ QoL scores decreased after surgery, which demonstrated the sensitivity of the questionnaire. The QoL scores in patients with lobectomy showed best QoL scores postoperatively and those with receiving radioactive iodine still showed decreased QoL scores along the postoperative periods.
Conclusion
These results demonstrate that KT-QoL is a valid instrument for evaluating QoL of Korean patients with thyroid cancer.

Citations

Citations to this article as recorded by  
  • Health-Related Quality of Life in Patients with Low-Risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy
    Kathy Bach, Palvishey Ansari, Hamayail Ansari, Nicole M. Mott, Dawn M. Elfenbein, Hunter Underwood, Susan C. Pitt
    Thyroid®.2024; 34(1): 14.     CrossRef
  • Longitudinal Changes in Quality of Life Before and After Thyroidectomy in Patients With Differentiated Thyroid Cancer
    Byung Hun Kim, Soo Rack Ryu, Jin Won Lee, Chang Myeon Song, Yong Bae Ji, Seok Hyun Cho, Seung Hwan Lee, Kyung Tae
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(6): 1505.     CrossRef
  • Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)
    Ja Kyung Lee, Eu Jeong Ku, Su-jin Kim, Woochul Kim, Jae Won Cho, Kyong Yeun Jung, Hyeong Won Yu, Yea Eun Kang, Mijin Kim, Hee Kyung Kim, Junsun Ryu, June Young Choi
    Annals of Surgical Treatment and Research.2024; 106(1): 19.     CrossRef
  • Five-Year Follow-Up of Health-Related Quality of Life in Differentiated Thyroid Cancer Patients Treated with Total Thyroidectomy and Radioiodine in Sweden: A Nationwide Prospective Cohort Study
    Julia Winter, Erland Axelsson, Linda Björkhem-Bergman, Catharina Ihre Lundgren, Christel Hedman
    Thyroid®.2024; 34(6): 713.     CrossRef
  • Assessment of preoperative health-related quality of life in patients undergoing thyroidectomy based on patient-reported outcomes
    Lei Liu, Yuqing Xiang, Lujing Xiong, Chao Li, Wei Dai, Jinchuan Hu, Chunyan Shui, Yuqiu Zhou, Xu Wang, Linjie Ma, Nan Xu, Bintao Hu, Yongcong Cai
    Frontiers in Psychology.2024;[Epub]     CrossRef
  • A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma Favoring Active Surveillance Over Surgery
    Ji Ye Lee, Dong Gyu Na, Jung Suk Sim, Jin Yong Sung, Sun Wook Cho, Do Joon Park, Young Joo Park, Ji-hoon Kim
    Thyroid®.2024; 34(9): 1126.     CrossRef
  • Comparison of Patient-Reported Outcomes Between Active Surveillance and Immediate Lobectomy in Patients with Low-Risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS Cohort
    Min Joo Kim, Hojeong Won, Won Bae Kim, Eun Kyung Lee, Chang Yoon Lee, Sun Wook Cho, Han-Sang Baek, Yong Sang Lee, Yea Eun Kang, Sun Wook Kim, Ho-Cheol Kang, Jeongmin Lee, Mijin Kim, Min Ji Jeon, Jae Hoon Moon
    Thyroid®.2024; 34(11): 1371.     CrossRef
  • Optimizing surgical outcomes in papillary thyroid carcinoma with Hashimoto’s Thyroiditis: a retrospective comparative study of unilateral and total thyroidectomy
    Xiaoyong Wen, Shiwei Zhou, Wu Li, Hui Li, Xiaohua Song, Yu Mao, Zeyu Li, Guangji Chen, Xiaowei Peng, Peng Wu
    Scientific Reports.2024;[Epub]     CrossRef
  • Quality of life in thyroid cancer
    Torquil Watt, Thea Christoffersen, Mathilde Borring Brogaard, Jakob Bue Bjorner, Jens Bentzen, Christoffer Holst Hahn, Birte Nygaard, Ulla Feldt-Rasmussen
    Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(1): 101732.     CrossRef
  • Systematic review of health-related quality of life following thyroid cancer
    Emma G Walshaw, Mike Smith, Dae Kim, Jonathan Wadsley, Anastasios Kanatas, Simon N. Rogers
    Tumori Journal.2022; 108(4): 291.     CrossRef
  • Factors affecting the health-promoting behavior of thyroid cancer survivors: comparison by stage of cancer survivorship
    Kyung Ah Park, Sanghee Kim, Eui Geum Oh, Heejung Kim, Hang-Seok Chang, Soo Hyun Kim
    Supportive Care in Cancer.2022; 30(4): 3429.     CrossRef
  • Care and Management of Voice Change in Thyroid Surgery: Korean Society of Laryngology, Phoniatrics and Logopedics Clinical Practice Guideline
    Chang Hwan Ryu, Seung Jin Lee, Jae-Gu Cho, Ik Joon Choi, Yoon Seok Choi, Yong Tae Hong, Soo Yeon Jung, Ji Won Kim, Doh Young Lee, Dong Kun Lee, GIljoon Lee, Sang Joon Lee, Young Chan Lee, Yong Sang Lee, Inn Chul Nam, Ki Nam Park, Young Min Park, Eui-Suk S
    Clinical and Experimental Otorhinolaryngology.2022; 15(1): 24.     CrossRef
  • Health-Related Quality of Life following Total Thyroidectomy and Lobectomy for Differentiated Thyroid Carcinoma: A Systematic Review
    Vivianne Landry, Elizabeth Siciliani, Melissa Henry, Richard J. Payne
    Current Oncology.2022; 29(7): 4386.     CrossRef
  • Effect of radioiodine therapy under thyroid hormone withdrawal on health-related quality of life in patients with differentiated thyroid cancer
    Hui Ming, Hui Yu, Yangbao Liu, Lihua Yang, Yuanhao Chen
    Japanese Journal of Clinical Oncology.2022;[Epub]     CrossRef
  • Thyroid disease‐specific quality of life questionnaires ‐ A systematic review
    Verena Uslar, Caroline Becker, Dirk Weyhe, Navid Tabriz
    Endocrinology, Diabetes & Metabolism.2022;[Epub]     CrossRef
  • Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma
    Jae Hoon Moon, Chang Hwan Ryu, Sun Wook Cho, June Young Choi, Eun-Jae Chung, Jeong Hun Hah, Yul Hwangbo, Woo-Jin Jeong, Yuh-Seog Jung, Ji-hoon Kim, Min Joo Kim, Su-jin Kim, Yeo Koon Kim, Chang Yoon Lee, Eun Kyung Lee, Ji Ye Lee, Kyu Eun Lee, You Jin Lee,
    The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): 724.     CrossRef
  • Singing voice range profile: New objective evaluation methods for voice change after thyroidectomy
    Jungirl Seok, Youn Mi Ryu, Seong Ae Jo, Chang Yoon Lee, Yuh‐Seog Jung, Junsun Ryu, Chang Hwan Ryu
    Clinical Otolaryngology.2021; 46(2): 332.     CrossRef
  • A Propensity Score Matching Study Between Microwave Ablation and Radiofrequency Ablation in Terms of Safety and Efficacy for Benign Thyroid Nodules Treatment
    Hao Jin, Jinrui Fan, Ligong Lu, Min Cui
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Adaptation transculturelle en Français du questionnaire évaluant la qualité de vie des patients opérés d’un cancer de la thyroïde : THYCA-QoL
    Boris Scheller, Joseph Santini, Amélie Anota, Gilles Poissonnet, Y. Chateau, Renaud Schiappa, Danielle Benisvy, Olivier Dassonville, Alexandre Bozec, Emmanuel Chamorey
    Bulletin du Cancer.2021; 108(7-8): 696.     CrossRef
  • A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial
    Eun Kyung Lee, You Jin Lee, Young Joo Park, Jae Hoon Moon, Ka Hee Yi, Koon Soon Kim, Joo Hee Lee, Sun Wook Cho, Jungnam Joo, Yul Hwangbo, Sujeong Go, Do Joon Park
    Endocrinology and Metabolism.2020; 35(3): 571.     CrossRef
  • Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study
    Massimo Giusti, Stefano Gay, Lucia Conte, Francesca Cecoli, Lorenzo Mortara, Lara Vera, Eleonora Monti
    European Thyroid Journal.2020; 9(5): 247.     CrossRef
  • Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro)
    Sung Hye Kong, Junsun Ryu, Min Joo Kim, Sun Wook Cho, Young Shin Song, Ka Hee Yi, Do Joon Park, Yul Hwangbo, You Jin Lee, Kyu Eun Lee, Su-jin Kim, Woo-Jin Jeong, Eun-Jae Chung, Jeong Hun Hah, June Young Choi, Chang Hwan Ryu, Yuh-Seog Jung, Jae Hoon Moon,
    Thyroid.2019; 29(8): 1089.     CrossRef
  • Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro)
    Jae Hoon Moon, Ji-hoon Kim, Eun Kyung Lee, Kyu Eun Lee, Sung Hye Kong, Yeo Koon Kim, Woo-jin Jung, Chang Yoon Lee, Roh-Eul Yoo, Yul Hwangbo, Young Shin Song, Min Joo Kim, Sun Wook Cho, Su-jin Kim, Eun Jae Jung, June Young Choi, Chang Hwan Ryu, You Jin Lee
    Endocrinology and Metabolism.2018; 33(2): 278.     CrossRef
  • 17,117 View
  • 331 Download
  • 24 Web of Science
  • 23 Crossref
Close layer
Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer
Ho-Sun Lee, Yunkyeong Kang, Kyung Tae, Gyu-Un Bae, Jong Y. Park, Yoon Hee Cho, Mihi Yang
Cancer Res Treat. 2018;50(1):111-117.   Published online March 8, 2017
DOI: https://doi.org/10.4143/crt.2017.001
AbstractAbstract PDFPubReaderePub
Purpose
For the target treatment and prevention of women’s increased thyroid cancer, we focused on risks of environmental exposure to endocrine disrupting chemicals, particularly bisphenol A (BPA), and its high susceptible exposure-timing, particularly early exposure in lives.
Materials and Methods
Female ICR mice were exposed to BPA in utero and in early life (15, 75, and 300 mg/L of drinking water via pregnant mice and lactation). We identified BPA-responsive proteins in mice thyroid by two-dimensional gel electrophoresis, image analyses, and electrospray ionization quadrupole time-of-flight mass spectrometry. We further analyzed expression of the BPA-responsive proteins in women thyroid cancer patients (n=28).
Results
We found the altered 17 proteins in BPA dose-dependent manner among the thyroid tissues of offspring mice and identified nine proteins of them, including Anxa6, Atp5b, Hspa5, and Vcp, etc. In addition, we observed the positive association between blood BPA levels and mRNA expression of the ANXA6 and VCP not in normal but thyroid cancer tissues.
Conclusion
Our study provides ANXA6 and VCP as proteomic biomarkers for BPA–early life exposure and their potential for women’s thyroid cancer.

Citations

Citations to this article as recorded by  
  • Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer
    Yingying Bai, Yandong Miao, Jiangtao Wang, Jian Gan, Jiang Feng
    Biochemical Genetics.2024;[Epub]     CrossRef
  • Subchronic toxic effects of bisphenol A on the gut-liver-hormone axis in rats via intestinal flora and metabolism
    Jiaqi Wang, Ce Su, Mingqin Qian, Xin Wang, Changlan Chen, Yangcheng Liu, Wei Liu, Zheng Xiang, Baoli Xu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer
    Huhu Zhang, Zhe Zhang, Tingting Guo, Guang Chen, Guoxiang Liu, Qinghang Song, Guichun Li, Fenghua Xu, Xiaolei Dong, Fanghao Yang, Can Cao, Di Zhong, Shuang Li, Ya Li, Mengjun Wang, Bing Li, Lina Yang
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Current Evidence on Bisphenol A Exposure and the Molecular Mechanism Involved in Related Pathological Conditions
    Ylenia Della Rocca, Enrico Matteo Traini, Francesca Diomede, Luigia Fonticoli, Oriana Trubiani, Alessia Paganelli, Jacopo Pizzicannella, Guya Diletta Marconi
    Pharmaceutics.2023; 15(3): 908.     CrossRef
  • ANXA6: a key molecular player in cancer progression and drug resistance
    Jinlong Cao, Shun Wan, Siyu Chen, Li Yang
    Discover Oncology.2023;[Epub]     CrossRef
  • Assessment of five typical environmental endocrine disruptors and thyroid cancer risk: a meta-analysis
    Yuyao Yang, Xiaoyue Bai, Juan Lu, Ronghao Zou, Rui Ding, Xiaohui Hua
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance
    Mai K. L. Nguyen, Jaimy Jose, Mohamed Wahba, Marc Bernaus-Esqué, Andrew J. Hoy, Carlos Enrich, Carles Rentero, Thomas Grewal
    International Journal of Molecular Sciences.2022; 23(13): 7206.     CrossRef
  • Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment
    Shrestha Dutta, Swatilekha Ghosh, Abhishek Mishra, Rajgourab Ghosh
    Journal of Proteins and Proteomics.2022;[Epub]     CrossRef
  • A comprehensive review on the carcinogenic potential of bisphenol A: clues and evidence
    Nadeem Ghani Khan, Jacinta Correia, Divya Adiga, Padmalatha Satwadi Rai, Herman Sunil Dsouza, Sanjiban Chakrabarty, Shama Prasada Kabekkodu
    Environmental Science and Pollution Research.2021; 28(16): 19643.     CrossRef
  • Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer
    Susan Costantini, Francesca Capone, Andrea Polo, Palmina Bagnara, Alfredo Budillon
    International Journal of Molecular Sciences.2021; 22(18): 10177.     CrossRef
  • Bisphenol A Activates an Innate Viral Immune Response Pathway
    Mark L. Sowers, Hui Tang, Bing Tian, Randall Goldblum, Terumi Midoro-Horiuti, Kangling Zhang
    Journal of Proteome Research.2020; 19(2): 644.     CrossRef
  • Ion-Trap Mass Spectrometric Analysis of Bisphenol A Interactions With Titanium Dioxide Nanoparticles and Milk Proteins
    Edward P.C. Lai, Hendrik Kersten, Thorsten Benter
    Molecules.2020; 25(3): 708.     CrossRef
  • ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
    Qianping Chen, Wang Zheng, Lin Zhu, Dan Yao, Chen Wang, Yimeng Song, Songling Hu, Hongxia Liu, Yang Bai, Yan Pan, Jianghong Zhang, Jian Guan, Chunlin Shao
    Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
  • Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies
    Olga Y. Korolkova, Sarrah E. Widatalla, Stephen D. Williams, Diva S. Whalen, Heather K. Beasley, Josiah Ochieng, Thomas Grewal, Amos M. Sakwe
    Cells.2020; 9(8): 1855.     CrossRef
  • Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
    Sarrah E Widatalla, Olga Y Korolkova, Diva S Whalen, J Shawn Goodwin, Kevin P Williams, Josiah Ochieng, Amos M Sakwe
    Carcinogenesis.2019; 40(8): 998.     CrossRef
  • Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
    Pamela D. Noyes, Katie Paul Friedman, Patience Browne, Jonathan T. Haselman, Mary E. Gilbert, Michael W. Hornung, Stan Barone, Kevin M. Crofton, Susan C. Laws, Tammy E. Stoker, Steven O. Simmons, Joseph E. Tietge, Sigmund J. Degitz
    Environmental Health Perspectives.2019;[Epub]     CrossRef
  • Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3�h
    Changqing Du, Yingzheng Weng, Jiangjie Lou, Guangzhong Zeng, Xiaowei Liu, Hongfeng Jin, Senna Lin, Lijiang Tang
    International Journal of Molecular Medicine.2019;[Epub]     CrossRef
  • Bisphenol A and estradiol impede myoblast differentiation through down-regulating Akt signaling pathway
    Ga-Yeon Go, Sang-Jin Lee, Ayoung Jo, Jae-Rin Lee, Jong-Sun Kang, Mihi Yang, Gyu-Un Bae
    Toxicology Letters.2018; 292: 12.     CrossRef
  • Determination of Highly Sensitive Biological Cell Model Systems to Screen BPA-Related Health Hazards Using Pathway Studio
    Do-Yeal Ryu, Md Rahman, Myung-Geol Pang
    International Journal of Molecular Sciences.2017; 18(9): 1909.     CrossRef
  • 13,106 View
  • 441 Download
  • 19 Web of Science
  • 19 Crossref
Close layer
Evaluation of Diagnostic Performance of Screening Thyroid Ultrasonography and Imaging Findings of Screening-Detected Thyroid Cancer
Jeongin Yoo, Hye Shin Ahn, Soo Jin Kim, Sung Hee Park, Mirinae Seo, Semin Chong
Cancer Res Treat. 2018;50(1):11-18.   Published online February 24, 2017
DOI: https://doi.org/10.4143/crt.2016.600
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to evaluate the diagnostic performance and cost of screening thyroid ultrasonography (US) in an asymptomatic population and determine the US features of screening-detected thyroid cancer.
Materials and Methods
This study included 1,845 asymptomatic participants who underwent screening thyroid US between March and August 2012 at the screening center in our hospital. We evaluated the diagnostic performance of screening thyroid US for thyroid cancer and the average cost of diagnosis for each patient. We also determined the characteristic US features of screening-detected thyroid cancer.
Results
Of the 1,845 subjects, 661 showed no abnormalities, 1,155 exhibited benign thyroid nodules, and 29 exhibited thyroid cancer. Imaging features such as solid composition, hypoechogenicity, taller-than-wide axis, and ill-defined or spiculated margins of nodules were suggestive of malignancy. The rate of detection of cancer was 1.6% (29/1,845), and the sensitivity, specificity, and positive and negative predictive values were 100% (18/18), 98.7% (1,051/1,065), 56.3% (18/32), and 100% (1,051/1,051), respectively. Of 18 patients who underwent thyroidectomy, three (16.7%) had a pathological tumor staging of T3, and four (22.2%) had a pathological nodal staging of N1a. The average cost of diagnosis for each patient with cancer was $7,319.
Conclusion
Screening thyroid US exhibited a good diagnostic performance, with a feasible social cost of use. This modality demonstrated significant differences in sonographic features between screening-detected cancer and benign nodules.

Citations

Citations to this article as recorded by  
  • Temporal Trends in Thyroid Nodule Size on Ultrasonography
    Hayley Mann, Natalia Arroyo, Vivian Hsiao, Franklin Tessler, Lori Mankowski Gettle, Yanchen Zhang, Abdullah Adil, Mary Hitchcock, Elian Massoud, Catherine Jensen, Oguzhan Alagoz, Louise Davies, Sara Fernandes-Taylor, David O. Francis
    JAMA Otolaryngology–Head & Neck Surgery.2025; 151(1): 47.     CrossRef
  • A nomogram based on clinicopathological and ultrasound characteristics to predict central neck lymph node metastases in papillary thyroid cancer
    Fei Chen, Shuiping Jiang, Fan Yao, Yixi Huang, Jiaxi Cai, Jia Wei, Chengxu Li, Yanxuan Wu, Xiaolin Yi, Zhen Zhang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Comparison of the value of ultrasound-guided fine needle aspiration biopsy and contrast-enhanced ultrasound in different sizes of thyroid nodules
    Qi Liu, Liquan Ouyang, Shengchu Zhang, Yuxia Yang
    Medicine.2024; 103(39): e39843.     CrossRef
  • Thyroid Ultrasonography Screening of a Cohort of Male University Students
    Mahmoud S. Babiker, Fathelrehman A. Alamin, Mohammed Almteri, Abdullah Alradaddi, Waleed Alharbi
    Journal of Diagnostic Medical Sonography.2024;[Epub]     CrossRef
  • Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study
    Jingjing Yang, Yu Sun, Xingjia Li, Yueting Zhao, Xue Han, Guofang Chen, Wenbo Ding, Ruiping Li, Jianhua Wang, Fangsen Xiao, Chao Liu, Shuhang Xu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Clinical and ultrasonography evaluation of thyroid tumor screening in symptomatic patient of Bajulmati primary care center, Banyuwangi, East Java, Indonesia
    Rosy Setiawati, Tri Wulanhandarini, Fierly Hayati, Dyah Erawati, Merlin Guntur Jaya, Andi Ahmad Thoriq, Triana Mediyawati Wijaya, Galih Nur Ismiyati, Dyan Wahyu Kusumaningrum, Belinda Koesmarsono, Agnes Triana Basja, M. Ikhsan Nugroho, Silvi Yuliana, Syad
    Medicine.2022; 101(52): e32546.     CrossRef
  • The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism
    Mechteld C. de Jong, K. Jamal, S. Morley, T. Beale, T. Chung, S. Jawad, S. Hurel, H. Simpson, U. Srirangalingam, S. E. Baldeweg, V. Rozalén García, S. Otero, M. Shawky, T. E. Abdel-Aziz, T. R. Kurzawinski
    Hormones.2021; 20(3): 499.     CrossRef
  • Sex Bias in Differentiated Thyroid Cancer
    Valentine Suteau, Mathilde Munier, Claire Briet, Patrice Rodien
    International Journal of Molecular Sciences.2021; 22(23): 12992.     CrossRef
  • Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma
    Antonio Travaglino, Mirella Pace, Silvia Varricchio, Luigi Insabato, Claudia Giordano, Marco Picardi, Fabrizio Pane, Stefania Staibano, Massimo Mascolo
    American Journal of Clinical Pathology.2020; 153(2): 156.     CrossRef
  • Changes in the Diagnostic Efficiency of Thyroid Fine-Needle Aspiration Biopsy during the Era of Increased Thyroid Cancer Screening in Korea
    Young Ki Lee, Kyeong Hye Park, Young Duk Song, Taemi Youk, Joo Young Nam, Sun Ok Song, Dong Yeob Shin, Eun Jig Lee
    Cancer Research and Treatment.2019; 51(4): 1430.     CrossRef
  • Sonographic Criteria Predictive of Malignant Thyroid Nodules
    Carlos Miguel Oliveira, Rui Alves Costa, Miguel Patrício, Amélia Estêvão, Bruno Graça, Filipe Caseiro-Alves
    Academic Radiology.2017;[Epub]     CrossRef
  • 11,222 View
  • 294 Download
  • 14 Web of Science
  • 11 Crossref
Close layer
Meta-Analysis
Alcohol Intake and Risk of Thyroid Cancer: A Meta-Analysis of Observational Studies
Seung-Hee Hong, Seung-Kwon Myung, Hyeon Suk Kim, The Korean Meta-Analysis (KORMA) Study Group
Cancer Res Treat. 2017;49(2):534-547.   Published online July 7, 2016
DOI: https://doi.org/10.4143/crt.2016.161
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to assess whether alcohol intake is associated with the risk of thyroid cancer by a meta-analysis of observational studies.
Materials and Methods
We searched PubMed and EMBASE in June of 2015 to locate eligible studies. We included observational studies such as cross-sectional studies, case-control studies, and cohort studies reporting odd ratios (ORs) or relative risk (RRs) with 95% confidence intervals (CIs).
Results
We included 33 observational studies with two cross-sectional studies, 20 case-controls studies, and 11 cohort studies, which involved a total of 7,725 thyroid cancer patients and 3,113,679 participants without thyroid cancer in the final analysis. In the fixed-effect model meta-analysis of all 33 studies, we found that alcohol intake was consistently associated with a decreased risk of thyroid cancer (OR or RR, 0.74; 95% CI, 0.67 to 0.83; I2=38.6%). In the subgroup meta-analysis by type of study, alcohol intake also decreased the risk of thyroid cancer in both case-control studies (OR, 0.77; 95% CI, 0.65 to 0.92; I2=29.5%; n=20) and cohort studies (RR, 0.70; 95% CI, 0.60 to 0.82; I2=0%; n=11). Moreover, subgroup meta-analyses by type of thyroid cancer, gender, amount of alcohol consumed, and methodological quality of study showed that alcohol intake was significantly associated with a decreased risk of thyroid cancer.
Conclusion
The current meta-analysis of observational studies found that, unlike most of other types of cancer, alcohol intake decreased the risk of thyroid cancer.

Citations

Citations to this article as recorded by  
  • Associations Between Obesity and Risk of Thyroid Cancer: A Meta-Analysis of Cohort Studies
    Urfa Khairatun Hisan, Seung-Kwon Myung, Giap Viet Nguyen
    Nutrition and Cancer.2025; 77(2): 288.     CrossRef
  • Nongenetic risk factors for thyroid cancer: an umbrella review of evidence
    Ge Peng, Xiaohui Pan, Ziwei Ye, Xianyanling Yi, Qingxing Xie, Xinyi Zhang, Nanwei Tong
    Endocrine.2025;[Epub]     CrossRef
  • Prevalence of thyroid nodule and relationship with physiological and psychosocial factors among adults in Zhejiang Province, China: a baseline survey of a cohort study
    Xueqing Li, Zhijian Chen, Lizhi Wu, Pengchen Tu, Zhe Mo, Mingluan Xing
    BMC Public Health.2024;[Epub]     CrossRef
  • The influence of nutrition in nodular thyroid pathology: a systematic review
    Vanessa Neto, Catarina Leitão, Marta Estrela, Margarida Fardilha, Maria Teresa Herdeiro, Alexandra Nunes
    Critical Reviews in Food Science and Nutrition.2024; : 1.     CrossRef
  • Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies
    Naouras Bouajila, Cloé Domenighetti, Henri-Jean Aubin, Mickael Naassila
    Frontiers in Epidemiology.2024;[Epub]     CrossRef
  • The Correlation Between Biological Markers and Prognosis in Thyroid Cancer
    Rami Hajjar, Ciprian Duta, Ionut Flaviu Faur, Catalin Prodan-Barbulescu, Hadi Alhajjar, Stelian Pantea
    Biomedicines.2024; 12(12): 2826.     CrossRef
  • Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach
    Raul Zamora-Ros, Valerie Cayssials, Ramon Clèries, Maria Torrents, Graham Byrnes, Elisabete Weiderpass, Maria Sandström, Martin Almquist, Marie-Christine Boutron-Ruault, Anne Tjønneland, Cecilie Kyrø, Verena A. Katzke, Charlotte Le Cornet, Giovanna Masala
    European Journal of Nutrition.2023; 62(1): 105.     CrossRef
  • Molecular Testing Results for Indeterminate Thyroid Nodules and Social Habits
    Hui Zheng, John F. Whitney, Victoria Lai
    Journal of Surgical Research.2023; 284: 245.     CrossRef
  • Smoking and alcohol consumption with the risk of 11 common otolaryngological diseases: a bidirectional Mendelian randomization
    Xu Wang, Yuewei Bi, Guangping Liu, Wei Wang, Hualei Cui
    European Archives of Oto-Rhino-Laryngology.2023; 280(12): 5615.     CrossRef
  • Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses
    Hailong Li, Yue Chen, Lei Hu, Wenzhi Yang, Zongshi Gao, Mengqing Liu, Hui Tao, Jie Li
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis
    Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Eun Jeong Choi, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park
    Epidemiology and Health.2023; 45: e2023092.     CrossRef
  • Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case–control studies
    Lucie Lécuyer, Nasser Laouali, Mariem Hajji-Louati, Melanie Paquet, Vincent Souchard, Mojgan Karimi, Claire Schvartz, Anne-Valérie Guizard, Constance Xhaard, Carole Rubino, Yan Ren, Françoise Borson-Chazot, Elisabeth Adjadj, Emilie Cordina-Duverger, Flore
    European Journal of Nutrition.2022; 61(2): 1097.     CrossRef
  • Association between Thyroid Cancer and Breast Cancer: Two Longitudinal Follow-Up Studies Using a National Health Screening Cohort
    Young Ju Jin, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, Hyo Geun Choi
    Journal of Personalized Medicine.2022; 12(2): 133.     CrossRef
  • Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study of 10 Million People
    Yohwan Yeo, Dong Wook Shin, Kyungdo Han, Dahye Kim, Tae Hyuk Kim, Sohyun Chun, Su-Min Jeong, Yun-Mi Song
    Thyroid.2022; 32(4): 440.     CrossRef
  • Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies
    Lixian Zhong, Weiwei Chen, Tonghua Wang, Qiuting Zeng, Leizhen Lai, Junlong Lai, Junqin Lin, Shaohui Tang
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
    Lucie Lécuyer, Nasser Laouali, Laure Dossus, Nitin Shivappa, James R. Hébert, Antonio Agudo, Anne Tjonneland, Jytte Halkjaer, Kim Overvad, Verena A. Katzke, Charlotte Le Cornet, Matthias B. Schulze, Franziska Jannasch, Domenico Palli, Claudia Agnoli, Rosa
    European Journal of Nutrition.2022; 61(7): 3625.     CrossRef
  • Are “Bad Habits” Good? The Relationships Between Smoking, Alcohol Use, and Thyroid Cancer
    Alex Tessnow
    Clinical Thyroidology.2022; 34(7): 309.     CrossRef
  • Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study
    Fjorida Llaha, Valerie Cayssials, Marta Farràs, Antonio Agudo, Maria Sandström, Anne Kirstine Eriksen, Anne Tjønneland, Marie-Christine Boutron-Ruault, Nasser Laouali, Thérèse Truong, Charlotte Le Cornet, Verena Katzke, Matthias Schulze, Domenico Palli, V
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Multiethnic genome‐wide association study of differentiated thyroid cancer in the EPITHYR consortium
    Thérèse Truong, Fabienne Lesueur, Pierre‐Emmanuel Sugier, Julie Guibon, Constance Xhaard, Mojgan Karimi, Om Kulkarni, Elise A. Lucotte, Delphine Bacq‐Daian, Anne Boland‐Auge, Claire Mulot, Pierre Laurent‐Puig, Claire Schvartz, Anne‐Valérie Guizard, Yan Re
    International Journal of Cancer.2021; 148(12): 2935.     CrossRef
  • Association of Polygenetic Risk Scores Related to Cell Differentiation and Inflammation with Thyroid Cancer Risk and Genetic Interaction with Dietary Intake
    Sang Shin Song, ShaoKai Huang, Sunmin Park
    Cancers.2021; 13(7): 1510.     CrossRef
  • Incidence and mortality from thyroid cancer in Latin America
    Fábia Cheyenne Gomes de Morais Fernandes, Dyego Leandro Bezerra de Souza, Maria Paula Curado, Talita Araujo de Souza, Arthur de Almeida Medeiros, Isabelle Ribeiro Barbosa
    Tropical Medicine & International Health.2021; 26(7): 800.     CrossRef
  • Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors
    Jun Park, Hyunju Park, Tae Hyuk Kim, Sun Wook Kim, Hye Won Jang, Jae Hoon Chung
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Changes in Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study
    Yohwan Yeo, Kyungdo Han, Dong-Wook Shin, Dahye Kim, Su-Min Jeong, Sohyun Chun, In-Young Choi, Keun-Hye Jeon, Tae-Hyuk Kim
    Cancers.2021; 13(10): 2343.     CrossRef
  • Der Tumormarker Thyreoglobulin
    K. Passek, N. Zulauf, M. H. Bendels, D. Quarcoo, G. M. Oremek
    Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie.2020; 70(1): 40.     CrossRef
  • Withdrawn: Smoking, alcohol consumption, and the risk of thyroid cancer: a population-based Korean cohort study of 10 million people
    Yohwan Yeo, Dong Wook Shin, Kyung-Do Han, Dahye Kim, Tae Hyuk Kim, Sohyun Chun, Sumin Jeong, Yun-Mi Song
    Thyroid.2020;[Epub]     CrossRef
  • Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data
    Soo-Hwan Byun, Chanyang Min, Hyo-Geun Choi, Seok-Jin Hong
    Genes.2020; 11(9): 1039.     CrossRef
  • A national database analysis for factors associated with thyroid cancer occurrence
    Joon-Hyop Lee, Sora Youn, Sohee Jung, Kwangsoo Kim, Young Jun Chai, Yoo Seung Chung, Won Seo Park, Kyu Eun Lee, Ka Hee Yi
    Scientific Reports.2020;[Epub]     CrossRef
  • Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer
    Soo-Youn An, So Young Kim, Dong Jun Oh, Chanyang Min, Songyoung Sim, Hyo Geun Choi
    Scientific Reports.2020;[Epub]     CrossRef
  • Human milk as a protective factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
    Jinglan Huang, Li Zhang, Jun Tang, Jing Shi, Yi Qu, Tao Xiong, Dezhi Mu
    Archives of Disease in Childhood - Fetal and Neonatal Edition.2019; 104(2): F128.     CrossRef
  • Leukocyte Mitochondrial DNA Copy Number and Risk of Thyroid Cancer: A Two-Stage Case-Control Study
    Jian Zheng, Ning-hua Cui, Shuai Zhang, Xue-bin Wang, Liang Ming
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Contemporary Debates in Adult Papillary Thyroid Cancer Management
    Donald S A McLeod, Ling Zhang, Cosimo Durante, David S Cooper
    Endocrine Reviews.2019; 40(6): 1481.     CrossRef
  • Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
    Nizhen Xu, Deguang Zhang, Jian Chen, Gaofei He, Li Gao
    Oncology Letters.2019;[Epub]     CrossRef
  • A Linkage Between Thyroid and Breast Cancer: A Common Etiology?
    Eric L. Bolf, Brian L. Sprague, Frances E. Carr
    Cancer Epidemiology, Biomarkers & Prevention.2019; 28(4): 643.     CrossRef
  • Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea
    Sarah Yang, Jeonghee Lee, Yoon Park, Eun Kyung Lee, Yul Hwangbo, Junsun Ryu, Joohon Sung, Jeongseon Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • Alcohol consumption and risk of hematological malignancies: A meta‐analysis of prospective studies
    Theodora Psaltopoulou, Theodoros N. Sergentanis, Ioannis Ntanasis‐Stathopoulos, Ioannis‐Georgios Tzanninis, Diamantis I. Tsilimigras, Meletios A. Dimopoulos
    International Journal of Cancer.2018; 143(3): 486.     CrossRef
  • Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies
    Yoon-Jung Choi, Seung-Kwon Myung, Ji-Ho Lee
    Cancer Research and Treatment.2018; 50(2): 474.     CrossRef
  • Thyroid Cancer Epidemiology in South Spain: a population-based time trend study
    Elena Salamanca-Fernández, Miguel Rodriguez-Barranco, Yoe-Ling Chang-Chan, Daniel Redondo-Sánchez, Santiago Domínguez-López, Eloísa Bayo, Dariusz Narankiewicz, José Expósito, María José Sánchez
    Endocrine.2018; 62(2): 423.     CrossRef
  • 12,918 View
  • 309 Download
  • 37 Web of Science
  • 37 Crossref
Close layer
Original Articles
Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults
Seung-Kwon Myung, Chan Wha Lee, Jeonghee Lee, Jeongseon Kim, Hyeon Suk Kim
Cancer Res Treat. 2017;49(1):70-78.   Published online June 23, 2016
DOI: https://doi.org/10.4143/crt.2015.310
AbstractAbstract PDFPubReaderePub
Purpose
Although the incidence of thyroid cancer in Korea has rapidly increased over the past decade, few studies have investigated its risk factors. This study examined the risk factors for thyroid cancer in Korean adults.
Materials and Methods
The study design was a hospital-based case-control study. Between August 2002 and December 2011, a total of 802 thyroid cancer cases out of 34,211 patients screened from the Cancer Screenee. Cohort of the National Cancer Center in South Korea were included in the analysis. A total of 802 control cases were selected from the same cohort, and matched individually (1:1) by age (±2 years) and area of residence for control group 1 and additionally by sex for control group 2.
Results
Multivariate conditional logistic regression analysis using the control group 1 showed that females and those with a family history of thyroid cancer had an increased risk of thyroid cancer, whereas ever-smokers and those with a higher monthly household income had a decreased risk of thyroid cancer. On the other hand, the analysis using control group 2 showed that a family history of cancer and alcohol consumption were associated with a decreased risk of thyroid cancer, whereas higher body mass index (BMI) and family history of thyroid cancer were associated with an increased risk of thyroid cancer.
Conclusion
These findings suggest that females, those with a family history of thyroid cancer, those with a higher BMI, non-smokers, non-drinkers, and those with a lower monthly household income have an increased risk of developing thyroid cancer.

Citations

Citations to this article as recorded by  
  • Narrative overview of possible preventive measures for differentiated thyroid carcinomas
    Maria Eduarda de Castro, Lucas Leite Cunha, Laura Sterian Ward
    Heliyon.2025; 11(1): e41284.     CrossRef
  • Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
    Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1095.     CrossRef
  • Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
    Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo
    Discover Oncology.2024;[Epub]     CrossRef
  • Thyroid Cancer Prevalence, Risk Exposure, and Clinical Features Among Transgender Female Veterans
    John David Christensen, Hiba T Basheer, Jose Joaquin Lado Abeal
    Journal of the Endocrine Society.2024;[Epub]     CrossRef
  • Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule
    Desalew Gedamu, Tariku Shimels, Daniel Kassie, Zewditu Chanyalew, Mebrahtu Eyasu
    JCO Global Oncology.2024;[Epub]     CrossRef
  • Emerging Strategies in Thyroid Cancer Immunotherapy: A Comprehensive Systematic Review and Meta-Analysis of Clinical Outcomes
    Daniel Alejandro Estrella Cornejo, Meylin Yalitza Carriel Alvarado, Norma Susana Chávez Villagómez, Alberto Dario Díaz Parra, María Fernanda Navas Espinosa
    Salud, Ciencia y Tecnología.2024; 4: 1241.     CrossRef
  • Prevalence of Thyroid Nodules and Predictive Factors for their Malignancy: Is there any Correlation between Level of TSH and Type of Malignancy?: A Cross Sectional Study
    Leila Moradi, Mohsen Hani Tabaei Zavareh, Ferdos Zaman, Anahita Shareghi Bruojeni, Seyed Amir Mohammad Taravati, Hossein Naderi Boldaji, Koushan Rostami, Seyedeh Ghazal Shahrokh
    Advanced Biomedical Research.2024;[Epub]     CrossRef
  • Research Progress on Risk Factors of Thyroid Cancer
    丽 焦
    Advances in Clinical Medicine.2024; 14(08): 400.     CrossRef
  • Relationship between Serum Levels of Selenium and Thyroid Cancer: A Systematic Review and Meta-Analysis
    Runhua Hao, Ping Yu, Lanlan Gui, Niannian Wang, Da Pan, Shaokang Wang
    Nutrition and Cancer.2023; 75(1): 14.     CrossRef
  • Oxidative stress mediates the associations between phthalate exposures and thyroid cancer/benign nodule risk
    Chong Liu, Long-Qiang Wang, Min Zhang, Yan-Ling Deng, Qiong Luo, Er-Nan Liu, Pan-Pan Chen, Yu Miao, Pan Yang, Qiang Zeng
    Environmental Pollution.2023; 326: 121462.     CrossRef
  • Selenium and thyroid diseases
    Fei Wang, Chunyu Li, Shaoxin Li, Lili Cui, Junyu Zhao, Lin Liao
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Preoperative evaluation of thyroid nodules – Diagnosis and management strategies
    Tapoi Dana Antonia, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
    Pathology - Research and Practice.2023; 246: 154516.     CrossRef
  • Evaluation of Thyroid Fine Needle Aspiration Biopsy Results: A Single Center Experience
    Baris KARAGÜN
    Acta Medica Alanya.2023; 7(1): 34.     CrossRef
  • Thyroid Nodules and Obesity
    Elpida Demetriou, Maria Fokou, Savvas Frangos, Panagiotis Papageorgis, Panayiotis A. Economides, Aliki Economides
    Life.2023; 13(6): 1292.     CrossRef
  • Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: A case-control study in China
    Haoran Li, Ming Yang, Jing Yang, Samuel Seery, Chaoying Ma, Yi Liu, Xiaoguang Zhang, Ang Li, Huicai Guo
    Chemosphere.2023; 337: 139411.     CrossRef
  • Interaction between Genetic Risks and Socioeconomic Factors on Thyroid Cancer: Evidence from 0.5 Million UK Biobank Participants
    Yu Li, Yongle Zhan, Wei Mao, Baoxin Wang, Pin Dong, Rong Na
    Cancers.2023; 15(20): 5028.     CrossRef
  • Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach
    Gabriela Maria Berinde, Andreea Iulia Socaciu, Mihai Adrian Socaciu, Andreea Cozma, Armand Gabriel Rajnoveanu, Gabriel Emil Petre, Doina Piciu
    Diagnostics.2022; 12(2): 318.     CrossRef
  • Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer
    Zhifu Xiao, Haixia Zhao
    Pharmacogenomics and Personalized Medicine.2022; Volume 15: 157.     CrossRef
  • The Effect of Gout on Thyroid Cancer Incidence: A Nested Case-Control Study Using a National Health Screening Cohort
    So Young Kim, Dae Myoung Yoo, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, Woo Jin Bang, Sung Kyun Kim, Hyo Geun Choi
    Journal of Personalized Medicine.2022; 12(6): 887.     CrossRef
  • Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer
    Tung Hoang, Eun Kyung Lee, Jeonghee Lee, Yul Hwangbo, Jeongseon Kim
    Endocrinology and Metabolism.2022; 37(3): 513.     CrossRef
  • Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
    Cristina Micali, Ylenia Russotto, Benedetto Maurizio Celesia, Laura Santoro, Andrea Marino, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo
    Infectious Disease Reports.2022; 14(5): 655.     CrossRef
  • Thyroid Cancer and Psoriasis: A Nested Case–Control Study
    So Young Kim, Dae Myoung Yoo, Juyong Chung, Hyo Geun Choi
    Diagnostics.2022; 12(10): 2297.     CrossRef
  • Association between Obesity Indexes and Thyroid Cancer Risk in Korean Women: Nested Case–Control Study
    Yoonyoung Jang, Taehwa Kim, Brian H. S. Kim, Boyoung Park
    Cancers.2022; 14(19): 4712.     CrossRef
  • Relationship Between Physical Activity Levels and Thyroid Cancer Risk: A Prospective Cohort Study in Korea
    Anh Quynh Bui, Madhawa Gunathilake, Jeonghee Lee, Eun Kyung Lee, Jeongseon Kim
    Thyroid.2022; 32(11): 1402.     CrossRef
  • Association Between Genetic Risk, Adherence to Healthy Lifestyle Behavior, and Thyroid Cancer Risk
    Xiuming Feng, Fei Wang, Wenjun Yang, Yuan Zheng, Chaoqun Liu, Lulu Huang, Longman Li, Hong Cheng, Haiqing Cai, Xiangzhi Li, Xing Chen, Xiaobo Yang
    JAMA Network Open.2022; 5(12): e2246311.     CrossRef
  • Insufficient iodine nutrition may affect the thyroid cancer incidence in China
    Lijun Fan, Fangang Meng, Yunyan Gao, Peng Liu
    British Journal of Nutrition.2021; 126(12): 1852.     CrossRef
  • Thyroid cancer and its associated factors: A population‐based case‐control study
    Mohammad Taher Parad, Mohammad Fararouei, Ali Reza Mirahmadizadeh, Sima Afrashteh
    International Journal of Cancer.2021; 149(3): 514.     CrossRef
  • Evaluation of the relationship between previous statin use and thyroid cancer using Korean National Health Insurance Service-Health Screening Cohort data
    So Young Kim, Young Shin Song, Jee Hye Wee, Chanyang Min, Dae Myoung Yoo, Chang-Ho Lee, Chang Myeon Song, Bumjung Park, Hyo Geun Choi
    Scientific Reports.2021;[Epub]     CrossRef
  • Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea
    Tung Hoang, Dayoung Song, Jeonghee Lee, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
    Cancer Research and Treatment.2021; 53(3): 857.     CrossRef
  • Reproductive and menstrual factors for papillary thyroid cancer risk: A case-control study in Chinese women
    Jia-liu He, Chi Zhang, Ming-jun Hu, Hua-bing Wu, Xue-lei Lu, Jia-hu Hao, Fen Huang
    Cancer Epidemiology.2021; 73: 101964.     CrossRef
  • Advanced thyroid carcinomas: neural network analysis of ultrasonographic characteristics
    Michael Cordes, Theresa Ida Götz, Elmar Wolfgang Lang, Stephan Coerper, Torsten Kuwert, Christian Schmidkonz
    Thyroid Research.2021;[Epub]     CrossRef
  • Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis
    Joon-Hyop Lee, Young Jun Chai, Ka Hee Yi
    Endocrinology and Metabolism.2021; 36(3): 590.     CrossRef
  • Epidemiologic, Clinical, Ultrasonographic, and Cytological Features of Thyroid Nodules in Predicting Malignancy Risk: A Retrospective Study of 442 French Afro-Caribbean Patients
    Johan Joseph-Auguste, Lucien Lin, Magalie Demar, Olivier Duffas, Vincent Molinie, Caroline Sulpicy, Marie-Josée Dorival, Olivier Luxembourger, Nadia Sabbah
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Serous BMP8A has Clinical Significance in the Ultrasonic Diagnosis of Thyroid Cancer and Promotes Thyroid Cancer Cell Progression
    Kun Liu, Min Gao, Dongdong Qin, Hongjun Wang, Qixiu Lu
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2020; 20(4): 591.     CrossRef
  • Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data
    Soo-Hwan Byun, Chanyang Min, Hyo-Geun Choi, Seok-Jin Hong
    Genes.2020; 11(9): 1039.     CrossRef
  • Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer
    Soo-Youn An, So Young Kim, Dong Jun Oh, Chanyang Min, Songyoung Sim, Hyo Geun Choi
    Scientific Reports.2020;[Epub]     CrossRef
  • Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer
    Katherine M. Polednik, Matthew C. Simpson, Eric Adjei Boakye, Kahee A. Mohammed, John J. Dombrowski, Mark A. Varvares, Nosayaba Osazuwa‐Peters
    The Laryngoscope.2019; 129(4): 1014.     CrossRef
  • Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
    Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
    Cancer Research and Treatment.2019; 51(4): 1392.     CrossRef
  • Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population
    Sitong Zhao, Xiaomeng Jia, Xiaojing Fan, Ling Zhao, Ping Pang, Yajing Wang, Yukun Luo, Fulin Wang, Guoqing Yang, Xianling Wang, Weijun Gu, Li Zang, Yu Pei, Jin Du, Jianming Ba, Jingtao Dou, Yiming Mu, Zhaohui Lyu
    Medicine.2019; 98(50): e18213.     CrossRef
  • Bethesda thyroid categories and family history of thyroid disease
    D. Kust, J. Staničić, N. Mateša
    Clinical Endocrinology.2018; 88(3): 468.     CrossRef
  • Thyroid cancer among female workers in Korea, 2007–2015
    Seonghoon Kang, Jinho Song, Taehwan Koh, One Park, Jong-Tae Park, Won-Jin Lee
    Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
  • Cigarette smoking and thyroid cancer risk: a cohort study
    Ara Cho, Yoosoo Chang, Jiin Ahn, Hocheol Shin, Seungho Ryu
    British Journal of Cancer.2018; 119(5): 638.     CrossRef
  • Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis
    Thaís Gomes de Melo, Ligia Vera Montali da Assumpção, Denise Engelbrecht Zantut-Wittmann
    International Journal of Endocrinology.2018; 2018: 1.     CrossRef
  • Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females
    Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
    Scientific Reports.2018;[Epub]     CrossRef
  • The Relationship Between Human Development Index and Its Components with Thyroid Cancer Incidence and Mortality: Using the Decomposition Approach
    Mokhtar Soheylizad, Salman Khazaei, Ensiyeh Jenabi, Ali Delpisheh, Yousef Veisani
    International Journal of Endocrinology and Metabolism.2018;[Epub]     CrossRef
  • Modern view on the risk factors for malignant tumors of the thyroid gland: a systematic review
    В. І. Ткаченко, Я. Ю. Рімар
    Family medicine.2018; (3): 57.     CrossRef
  • 14,529 View
  • 439 Download
  • 50 Web of Science
  • 46 Crossref
Close layer
Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck
Jae Myoung Noh, Sang Yun Ha, Yong Chan Ahn, Dongryul Oh, Seung Won Seol, Young Lyun Oh, Joungho Han
Cancer Res Treat. 2015;47(3):436-440.   Published online November 17, 2014
DOI: https://doi.org/10.4143/crt.2013.184
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to assess the clinicopathologic features, treatment outcomes, and role of adjuvant radiation therapy (RT) in cervical thymic neoplasm involving the thyroid gland or neck. Materials and Methods The medical and pathologic records of eight patients with cervical thymic neoplasm were reviewed retrospectively. All patients underwent surgical resection, including thyroidectomy or mass excision. Adjuvant RT was added in five patients with adverse clinicopathologic features. The radiation doses ranged from 54 Gy/27 fractions to 66 Gy/30 fractions delivered to the primary tumor bed and pathologically involved regional lymphatics using a 3-dimensional conformal technique. Results Eight cases of cervical thymic neoplasm included three patients with carcinoma showing thymus-like differentiation (CASTLE) and five with ectopic cervical thymoma. The histologic subtypes of ectopic cervical thymoma patients were World Health Organization (WHO) type B3 thymoma in one, WHO type B1 thymoma in two, WHO type AB thymoma in one, and metaplastic thymoma in one, respectively. The median age was 57 years (range, 40 to 76 years). Five patients received adjuvant RT: three with CASTLE; one with WHO type B3; and one with WHO type AB with local invasiveness. After a median follow-up period of 49 months (range, 11 to 203 months), no recurrence had been observed, regardless of adjuvant RT. Conclusion Adjuvant RT after surgical resection might be worthwhile in patients with CASTLE and ectopic cervical thymoma with WHO type B2-C and/or extraparenchymal extension, as similarly indicated for primary thymic epithelial tumors. A longer follow-up period may be needed in order to validate this strategy.

Citations

Citations to this article as recorded by  
  • Coexistence of intrathyroid thymic carcinoma and papillary thyroid carcinoma: a case report and literature review
    Maryam Vajihinejad, Ali Ataei, Mohammad Pashmchi, Ali Aledavoud, Vahid Zand, Mohammad Ali Broomand, Mohammad Mohammadi, Niloofar Zare Reshkuiyeh
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Case report: Thymoid differentiated carcinoma of thyroid: Two cases
    Yanjie Zhao, Jiafeng Liu
    Frontiers in Surgery.2023;[Epub]     CrossRef
  • Ectopic Cervical Thymoma: An Uncommon Entity
    Nikitha Kairanna, Geetha Vasudevan, Veena Karanth, Krishna Sharan
    Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S3): 5884.     CrossRef
  • Genomic variation associated with carcinoma showing thymus‐like elements (CASTLE) in thyroid gland
    Lin Jiang, Wei‐Hui Zheng, Chao Chen
    Laryngoscope Investigative Otolaryngology.2022; 7(3): 894.     CrossRef
  • Thyroid Carcinoma Showing Thymus-like Differentiation (CASTLE): A Case Report
    Mihaela Stanciu, Ruxandra Paula Ristea, Mihaela Popescu, Corina Maria Vasile, Florina Ligia Popa
    Life.2022; 12(9): 1314.     CrossRef
  • Failure pattern and suggestions for target volume delineation of carcinoma showing thymus-like differentiation treated with intensity-modulated radiotherapy
    Fang-Fang Kong, Guang-Sen Pan, Rui-Ping Zhai, Cheng-Run Du, Xia-Yun He, Chun-Ying Shen, Xue-Guan Lu, Tuan-Qi Sun, Yu Wang, Qing-Hai Ji, Chao-Su Hu, Hong-Mei Ying
    BMC Cancer.2022;[Epub]     CrossRef
  • Overview of the 2022 WHO Classification of Thyroid Neoplasms
    Zubair W. Baloch, Sylvia L. Asa, Justine A. Barletta, Ronald A. Ghossein, C. Christofer Juhlin, Chan Kwon Jung, Virginia A. LiVolsi, Mauro G. Papotti, Manuel Sobrinho-Simões, Giovanni Tallini, Ozgur Mete
    Endocrine Pathology.2022; 33(1): 27.     CrossRef
  • Thyroid carcinoma with thymus-like differentiation (CASTLE) tumor: а сase report
    A. A. Ilyin, V. V. Polkin, P. A. Isaev, F. E. Sevrukov, N. Yu. Dvinskych, M. I. Ryzhenkova, S. A. Ivanov, A. D. Kaprin
    Head and Neck Tumors (HNT).2021; 11(2): 64.     CrossRef
  • Recurrence of carcinoma showing thymus-like differentiation (CASTLE) involving the thyroid gland
    N. V. Dang, L. X. Son, N. T. T. Hong, N. T. T. Nhung, N. T. Tung, L. V. Quang
    Thyroid Research.2021;[Epub]     CrossRef
  • An extrathyroid CASTLE tumor in the left neck
    Lin Jiang, Wei-hui Zheng, Yun Xi, Chao Chen
    Oral Oncology.2020; 109: 104656.     CrossRef
  • The ‘CASTLE’ tumour: An extremely rare presentation of a thyroid malignancy. A case report
    Diana Mellisa Dualim, Loo Guo Hou, Shahrun Niza Abdullah Suhaimi, Nani Harlina Md Latar, Rohaizak Muhammad, Nordashima Abd Shukor
    Annals of Medicine and Surgery.2019;[Epub]     CrossRef
  • Ektopien des Thymus und ektope Thymustumoren
    A. Marx, T. Rüdiger, E. Rößner, A. Tzankov, V. T. de Montpréville, R. R. Rieker, P. Ströbel, C.‑A. Weis
    Der Pathologe.2018; 39(5): 390.     CrossRef
  • CASTLE Thyroid Tumor: A Case Report and Literature Review
    Chris Lominska, Christopher Fleighton Estes, Prakash C. Neupane, Y. Shnayder, Mindi J. TenNapel, Maura F. O’Neil
    Frontiers in Oncology.2017;[Epub]     CrossRef
  • Thyroid Carcinoma Showing Thymic-Like Differentiation Causing Fracture of the Trachea
    Aikaterini Marini, Meletios Kanakis, Konstantinos Valakis, Nikolaos Laschos, Maria Chorti, Achilleas Lioulias
    Case Reports in Medicine.2016; 2016: 1.     CrossRef
  • 12,002 View
  • 92 Download
  • 18 Web of Science
  • 14 Crossref
Close layer
Setting a Health Policy Research Agenda for Controlling Cancer Burden in Korea
Sung-In Jang, Kyoung-Hee Cho, Sun Jung Kim, Kwang-Sig Lee, Eun-Cheol Park
Cancer Res Treat. 2015;47(2):149-157.   Published online September 11, 2014
DOI: https://doi.org/10.4143/crt.2013.167
AbstractAbstract PDFPubReaderePub
Purpose
The aim of study was to provide suggestions for prioritizing research in effort to reduce cancer burden in Korea based on a comprehensive analysis of cancer burden and Delphi consensus among cancer experts. Materials and Methods Twenty research plans covering 10 topics were selected based on an assessment of the literature, and e-mail surveys were analyzed using a two-round modified Delphi method. Thirty-four out of 79 experts were selected from four organizations to participate in round one, and 21 experts among them had completed round two. Each item had two questions; one regarding the agreement of the topic as a priority item to reduce cancer burden, and the other about the importance of the item on a nine-point scale. A consensus was defined to be an average lower coefficient of variation with less than 30% in importance. Results Seven plans that satisfied the three criteria were selected as priority research plans for reducing cancer burden. These plans are “research into advanced clinical guidelines for thyroid cancer given the current issue with over-diagnosis,” “research into smoking management plans through price and non-price cigarette policy initiatives,” “research into ways to measure the quality of cancer care,” “research on policy development to expand hospice care,” “research into the spread and management of Helicobacter pylori,” “research on palliative care in a clinical setting,” and “research into alternative mammography methods to increase the accuracy of breast cancer screenings.” Conclusion The seven plans identified in this study should be prioritized to reduce the burden of cancer in Korea. We suggest that policy makers and administrators study and invest significant effort in these plans.

Citations

Citations to this article as recorded by  
  • An assessment for health education and health promotion in chronic disease demonstration districts: a comparative study from Hunan Province, China
    Qiaohua Xu, Biyun Chen, Donghui Jin, Li Yin, Yuelong Huang
    PeerJ.2019; 7: e6579.     CrossRef
  • Cancer, Stress, and Ironies of Cancer Understanding in South Korea
    Laura C. Nelson
    Medical Anthropology.2017; 36(1): 19.     CrossRef
  • Factors associated with quality of life among family caregivers of terminally ill cancer patients
    Youn Seon Choi, Sun Wook Hwang, In Cheol Hwang, Yong Ju Lee, Young Sung Kim, Hyo Min Kim, Chang Ho Youn, Hong Yup Ahn, Su-Jin Koh
    Psycho-Oncology.2016; 25(2): 217.     CrossRef
  • Is a Price Increase Policy Enough for Adolescent Smokers?: Factors Affecting the Effectiveness of Increasing Cigarette Prices Among Korean Adolescent Smokers
    Yong Suk Lee, Hong-Suk Kim, Hyung-Do Kim, Ki-Bong Yoo, Sung-In Jang, Eun-Cheol Park
    Nicotine & Tobacco Research.2016; 18(10): 2013.     CrossRef
  • 13,084 View
  • 67 Download
  • 4 Web of Science
  • 4 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP